Oral pilocarpine for radiation-induced xerostomia - A randomized, double-blind, placebo-controlled trial

Japanese Pharmacology and Therapeutics

Volumn 35, Issue SUPPL. 2, 2007, Pages

  Konno, Akiyoshi ^a   Nishio, Masamichi ^b   Origasa, Hideki ^c  

^a Southern Tohoku General Hospital   (Japan)

^b HOKKAIDO CANCER CENTER   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Double blind study; Oral pilocarpine; PhaseIII; Radiation induced xerostomia

Indexed keywords

PILOCARPINE;

ARTICLE; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTICATION; MULTICENTER STUDY; PATIENT ASSESSMENT; RADIATION INDUCED XEROSTOMIA; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP; SPEECH; SWEATING; VISUAL ANALOG SCALE; XEROSTOMIA;

EID: 37349012610     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Chambers MS, Garden AS, Kies MS, et al. Radiation-induced xerostomia in patients with head and neck cancer : pathogenesis, impact on quality of life, and management. Head Neck 2004 ; 26 : 796-807.
2. Shaha AR, Patel S, Shasha D, Harrison LB. Head and neck cancer. In : Lenhard RE Jr, Osteen RT, Gansler T, editors. Clinical oncology. Atlanta, GA : American Cancer Society ; 2001. p.297-330.
3. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993 ; 329 : 390-5.
4. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In : Hardman JG, Limbird LE, Goodman Gilman A, editors. Goodman & Gilman's the pharmacologic basis of therapeutics. 10th ed. New York : McGrawHill ; 2001. p.155-73.
5. Lynda R. Wiseman, Diana Faulds. Oral pilocarpine : a review of its pharmacological properties and clinical potential in xerostomia. Drugs 1995 ; 49 : 143-55.
6. LeVeque FG, Montgomery M, Potter D, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 1993 ; 11 : 1124-31.
7. Vivino FB, Al-Hashimi I, Khan Z, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome : a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med 1999 ; 159 : 174-81.
8. Salagen [package insert]. Minneapolis, MN : MGI Pharma, Inc ; April 1998.
9. Wasnich R, Gallagher S, Stanek S, et al. Salivary flow rates and pharmacokinetics in healthy Japanese and Caucasian volunteers administered oral pilocarpine : a comparative study. Clin Drug Invest 2003 ; 23 : 411-7.
10. Rieke JW, Hafermann MD, Johnson JT, et al. Oral pilocarpine for radiation-induced xerostomia : Integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiation Oncol Biol Phys 1995 ; 31 : 661-9.
11. Jacobs CD, van der Pas M. A multicenter maintenance study of oral pilocarpine tablets for radiation-induced xerostomia. Oncology 1996 ; 10 (Suppl) : 16-20.